Get more treatment options for your patients

Become a partner and turn molecular genomic reports into highly evidenced personalized treatment protocols.

Thank you. A member of our team will reach out to you shortly.

Oops! Something went wrong while submitting the form.

"In today's world of personalized cancer therapy it's important to understand the genetic and metabolic fingerprint of each tumour in order to determine the most appropriate combinations of drugs"

Dr Andrew Gaya

Consultant Clinical Oncologist at the Cromwell Hospital

"Astron's evidence-based innovation..... could rapidly become a transformative approach to oncology"

Dr Ndaba Mazibuko

Research Fellow at Kings College London

Our team have led teams and studied at some of the world's top research organisations

How Astron Works

Upload Results

Patient uploads their molecular genomic test results and other medical history

Analysis

Our molecular tumour board analyzes the test results using our proprietary treatment database

Report Creation

We generate a personalized report, listing candidate therapies and the peer-reviewed research, targeting both direct action and synthetic lethality vulnerabilities

Clinical Decision

The clinician receives the report and makes the final decision on what to prescribe

Extended Precision Oncology

Molecular tests can identify 1000s of mutations, but conventional precision oncology can only target fewer than 50 of these.
‍
Astron's Extended Precision Oncology reports cover this gap, giving highly evidenced personalized treatment options that target 1000s of gene mutations.

When can you use Astron in your practice?

Upon confirmation of cancer

Establish a baseline molecular profile of the tumor to guide treatment decisions.

Primary treatment completion

Prevent recurrence and stabilize the disease in the minimal residual disease (MRD) state.

Early signs of relapse

Intervene before relapse manifests on imaging.

Imaging or symptom progression

Adapt therapies based on tumor evolution and emerging resistance mechanisms.

Why partner with Astron?

Increased evidence-based treatment options for your patients

Save time on rigid molecular analysis and research

Co-authoring opportunities for peer reviewed publications

AI-driven treatment insights based on real-world data

Get more patients by offering precision oncology services, with direct referrals from Astron Health

Contribute longitudinal data and receive generous compensation

Shape your partnership with Astron Health as a founding partner

What patients are saying about Astron

"With these treatments I've got optionality and that makes a huge difference psychologically"

Paul

Astron Patient

"Practically tackling issues specific to my cancer has quite simply been life changing"

Judith

Astron Patient

"I've taken control in some way, you know. I want to know I've ticked every box."

Carol

Astron Patient

Current Clinical Research

An observational study evaluating longitudinal Minimal Residual Disease (MRD) status in potentially curable Pancreatic Ductal Adenocarcinoma (PDAC) following definitive treatment.

Get your practice involved in co-authoring our ground breaking clinical study or clinical registry study at the forefront of precision oncology.

Learn More

Become a founding Astron Partner

Collaborating with Astron can enhance patient outcomes, streamline clinic operations and success whilst provide opportunities for co-authoring in leading scientific publications.

Become A Partner